COVID-19 Impact: What Challenges Home Infusion Therapy Market May See In Next 5 Years?

Pune, Maharashtra,India, November 9 2020 (Wiredrelease) Origius Systems Private Limited –:The abrupt occurrence of COVID-19 pandemic has made a positive impact on the growth of the global home infusion therapy market in 2020. The growing geriatric population and rising cases of severe disorders are boosting the adoption of home infusion therapy during the COVID-19 crisis. Growing product launches and technological developments by leading companies is estimated to bring in rewarding opportunities for the growth of the global market during the pandemic period.

The newest research report on the global home infusion therapy market by Research Dive reveals the impact of the COVID-19 pandemic on the present and forthcoming growth of the market. This report is a meticulous research formulated by experts by reviewing regional market conditions, major driving factors, recent trends and developments, and size & scope of the market during the crisis period.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/360

Highlights of the Report

The sudden outbreak of the COVID-19 pandemic has imposed a positive impact on the global home infusion therapy market. According to the report, the global home infusion therapy market had garnered a revenue of $20.2 billion in 2019 and is expected to exceed $49.5 billion by 2027, rising at a CAGR of 11.7% during the crisis period. The size of the market in the current scenario has reached $22.9 billion due to the increased adoption of home infusion therapy by patients during the COVID-19 turmoil.

Factors Impacting the Market Growth during COVID-19 Pandemic

The global home infusion therapy market is expected to witness significant growth due to the global rise in the cases of acute diseases and growth in the geriatric population that needs long-term medical treatments. Furthermore, growing preference for home-based treatment by sick people, which have low immunity, to avoid getting affected by the COVID-19 infection is boosting the demand for home infusion therapy and leading to an augmented growth of the market.

Current Market Scenario Due to COVID-19:

In the course of the pandemic period, some of the leading players in the home infusion therapy market are undertaking various strategies such as collaborations, partnerships, and new product development to withstand their market position. For example, in July 2020, Biocon biologics, an innovation led fully integrated biopharmaceutical firm, and Voluntis, a healthcare software company specialized in Patient Relationship Management (PRM), entered into a partnership to develop and offer advanced digital therapeutics based on biologics therapy for supporting diabetes patients.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/360

On the other hand, government bodies in various COVID-19 affected areas are offering support to the home infusion therapy market players to sustain their business amidst the COVID-19 disaster. For example, in October 2019, the Medicare & Medicaid Services Centers have passed a law proclaiming that all home infusion therapy overheads will get covered under the Bipartisan Budget Act of 2018.

Future Scope of the Market:

As per the report, the global home infusion therapy market is expected to experience incessant growth post-coronavirus pandemic. New players and some of the major players including –

1. Fresenius Kabi
2. Baxter International, Inc.
3. Smiths Medical
4. JMS Co., Ltd.
5. ICU Medical Inc.
6. Terumo Corporation
7. Eli Lilly and Company
8. Becton
9. Dickinson and Company (BD)
10. B Braun Melsungen AG
11. Cosmed

And others are expected to mold the future of the global home infusion therapy market in the upcoming years. Quick Download Top Companies Development Strategies Summary Report

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

This content has been published by Origius Systems Private Limited company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.